Common Variant in PLD3 Influencing Cerebrospinal Fluid Total Tau Levels and Hippocampal Volumes in Mild Cognitive Impairment Patients from the ADNI Cohort
Restricted accessBrief reportFirst published online September 11, 2018
Common Variant in PLD3 Influencing Cerebrospinal Fluid Total Tau Levels and Hippocampal Volumes in Mild Cognitive Impairment Patients from the ADNI Cohort
Recent studies found the variants in Alzheimer’s disease (AD) risk gene PLD3 were associated with cognitive function, but its detailed mechanism before typical AD onset was unknown. Our current study examined the impact of PLD3 common variant rs11667768 on cerebrospinal fluid (CSF) total-tau and phosphorylated-tau levels and structural MRI from the ADNI database. We found rs11667768 was significantly associated with CSF total-tau levels and hippocampal volumes at baseline and six-year follow-up in the total non-demented elderly group and the mild cognitive impairment subgroup, indicating a potential role of PLD3 common variants in influencing cognitive function through changing CSF total-tau levels and hippocampal volumes.
WangC, TanL, WangHF, YuWJ, LiuY, JiangT, TanMS, HaoXK, ZhangDQ, YuJT (2015) Common variants in PLD3 and correlation to amyloid-related phenotypes in Alzheimer’s disease. J Alzheimers Dis46, 491–495.
5.
EngelmanCD, DarstBF, BilgelM, VasiljevicE, KoscikRL, JedynakBM, JohnsonSC (2018) The effect of rare variants in TREM2 and PLD3 on longitudinal cognitive function in the Wisconsin Registry for Alzheimer’s Prevention. Neurobiol Aging66, 177e171ߝ177e175.
6.
LinE, TsaiSJ, KuoPH, LiuYL, YangAC, KaoCF (2017) Association and interaction effects of Alzheimer’s disease-associated genes and lifestyle on cognitive aging in older adults in a Taiwanese population. Oncotarget8, 24077–24087.
7.
SperlingRA, AisenPS, BeckettLA, BennettDA, CraftS, FaganAM, IwatsuboT, JackCRJr, KayeJ, MontineTJ, ParkDC, ReimanEM, RoweCC, SiemersE, SternY, YaffeK, CarrilloMC, ThiesB, Morrison-BogoradM, WagsterMV, PhelpsCH (2011) Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 280–292.
8.
BennettDA, SchneiderJA, WilsonRS, BieniasJL, ArnoldSE (2004) Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol61, 378–384.
WangC, WangHF, TanMS, LiuY, JiangT, ZhangDQ, TanL, YuJT (2016) Impact of common variations in PLD3 on neuroimaging phenotypes in non-demented elders. Mol Neurobiol53, 4343–4351.
